FDA approves wider use of AstraZeneca's Crestor

02/8/2010 | Wall Street Journal, The

AstraZeneca obtained FDA approval to promote the use of cholesterol drug Crestor to prevent cardiovascular disease in patients with normal or moderately high cholesterol levels. AstraZeneca's application was supported by a study showing a 44% reduction in the number of cardiovascular events in Crestor recipients with a high C-reactive protein level after an average of nearly two years.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Compliance Specialist
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC
Regulatory Senior Managing/Principal Engineer/Scientist
Exponent
Menlo Park, CA
Director of Claims
Meridian Health Plan
Detroit, MI